A Study of Lenalidomide and CC-486 With Radiation Therapy in Patients With Plasmacytoma
Conditions:   Plasmacytoma;   Plasmacytoma of Bone;   Multiple Myeloma Interventions:   Drug: CC-486;   Drug: Lenalidomide;   Radiation: Radiation Therapy Sponsor:   Memorial Sloan Kettering Cancer Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2019 Category: Research Source Type: clinical trials